Supriti Pharmaceuticals Private Limited
About Supriti Pharmaceuticals Private Limited
Data last updated:
Supriti Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 14 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24239UR2020PTC011868. Its GSTIN is 05ABFCS0901B1Z3 (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nishad Arora and Amit Suri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15 Preet Vihar, Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2022, the company reported a revenue of ₹59.94 Lakh. For the same year it recorded a net loss of ₹1.35 Lakh (net margin -2.3%) and EBITDA of -₹32.09 Lakh (EBITDA margin -53.5%).
Company details
Contact details
Supriti Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered Address15 Preet Vihar, Dehradun, Uttarakhand, India – 248001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Supriti Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Supriti Pharmaceuticals Private Limited
FY 2025 filings availableSupriti Pharmaceuticals Private Limited reported revenue of ₹59.94 Lakh for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹59.94 Lakh | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹32.09 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.35 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -53.5% | |
| Net Profit Margin | -2.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Supriti Pharmaceuticals Private Limited, buy the company report.
Board of directors of Supriti Pharmaceuticals Private Limited
Supriti Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nishad Arora | Director | 05 Jan 2021 | 5 Years 10 Months | Current |
| Amit Suri | Director | 05 Jan 2021 | 5 Years 10 Months | Current |
| Preetika Suri | Director | 14 Dec 2020 | 5 Years 10 Months | Current |
| Sunita Jolly | Director | 14 Dec 2020 | 5 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Supriti Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supriti Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Supriti Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 22, 2024.
GST
Supriti Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05ABFCS0901B1Z3 | Uttarakhand | Active | 17 Mar 2021 |
To see the full GST registrations and return filing status of Supriti Pharmaceuticals Private Limited, buy the company report.
Recent activity
Supriti Pharmaceuticals Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Amit Suri was appointed as Director on 05 Jan 2021.
Frequently asked questions
Supriti Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 14 December 2020 (6+ years old) and is registered under CIN U24239UR2020PTC011868.
Supriti Pharmaceuticals has 4 current directors:
- Nishad Arora - Director
- Amit Suri - Director
- Preetika Suri - Director
- Sunita Jolly - Director
The latest financial statements of Supriti Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Supriti Pharmaceuticals is 05ABFCS0901B1Z3, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Supriti Pharmaceuticals is U24239UR2020PTC011868. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supriti Pharmaceuticals was incorporated on 14 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Amit Suri was appointed as Director on 05 Jan 2021. Nishad Arora was appointed as Director on 05 Jan 2021. Preetika Suri was appointed as Director on 14 Dec 2020. Supriti Pharmaceuticals has 4 board changes on record in total.
The registered office of Supriti Pharmaceuticals is at 15 Preet Vihar, Dehradun, Uttarakhand, India – 248001.
Supriti Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Supriti Pharmaceuticals can be reached at its registered office: 15 Preet Vihar, Dehradun, Uttarakhand, India – 248001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
